Relatively less is known about the interactions that tightly regulate the mesenchymal stem
cells (MSCs) to maintain their pluripotency. Recent studies reports that Wnt proteins might …

Mesenchymal stem cells (MSCs) are a heterogeneous cell population that is isolated initially
from the bone marrow (BM) and subsequently almost all tissues including umbilical cord …

Umbilical cord mesenchymal stem cells (UC-MSCs) have several advantages for clinical
therapy: the material is easily obtainable, the donation procedure is painless and there is …

Mesenchymal stem cells (MSCs) are multipotent precursor cells originating from several
adult connective tissues. MSCs possess the ability to self-renew and differentiate into …

Mesenchymal stromal cells (MSCs) are applied as novel therapeutics for their regenerative
and immune-suppressive capacities. Clinical applications, however, require extensive …

The placenta and umbilical cord are pre‐eminent candidate sources of mesenchymal stem
cells (MSCs). However, placenta‐derived MSCs (P‐MSCs) showed greater proliferation …

This study examines the role of Wnt signaling events in regulating the differential potential of
mesenchymal stem cells (MSCs) from adult bone marrow (BM). Immunohistochemical …

Mesenchymal stem cells are pluripotent cells from bone marrow, which can be differentiated
into the osteogenic, chondrogenic, and adipogenic lineages in vitro and are a source of cells …

The canonical Wnt signaling pathway can determine human bone marrow stromal
(mesenchymal) stem cell (hMSC) differentiation fate into osteoblast or adipocyte lineages …

Umbilical cord mesenchymal stem cells (UC-MSCs) have certain advantages over other
MSCs and about 300 clinical trials have been registered using UC-MSCs to treat diseases …